ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,894 | +85.6% | 13,298 | +131.4% | 0.00% | 0.0% |
| Q2 2023 | $21,490 | +195263.6% | 5,746 | +82.1% | 0.00% | – |
| Q1 2023 | $11 | -89.1% | 3,156 | -85.0% | 0.00% | -100.0% |
| Q4 2022 | $101 | -99.9% | 21,044 | +18.2% | 0.00% | +100.0% |
| Q3 2022 | $102,000 | -38.9% | 17,805 | -24.2% | 0.00% | -50.0% |
| Q2 2022 | $167,000 | +1755.6% | 23,502 | +1709.2% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 1,299 | +3.7% | 0.00% | – |
| Q4 2021 | $11,000 | -95.2% | 1,253 | -81.0% | 0.00% | -100.0% |
| Q3 2021 | $231,000 | +541.7% | 6,589 | +292.0% | 0.01% | +500.0% |
| Q2 2021 | $36,000 | -20.0% | 1,681 | +130.6% | 0.00% | 0.0% |
| Q1 2021 | $45,000 | +221.4% | 729 | +119.6% | 0.00% | – |
| Q4 2020 | $14,000 | – | 332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |